PRO-232 in Patients Subjected to Cataract Surgery

NCT07305987 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

134

Enrollment

INDUSTRY

Sponsor class

Conditions

Cataract Extraction

Interventions

DRUG: Moxifloxacin / Dexamethasone Ophthalmic Solution
DRUG: Placebo
DRUG: Moxifloxacin Hydrochloride, Ophthalmic
DRUG: Dexamethasone phosphate

Sponsor

Laboratorios Sophia S.A de C.V.